Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma.
Jun LiLei JinYuan GaoPeng GaoLe MaBei ZhuXu YinShizhen SuiShuai ChenZijian JiangChunfu ZhuPublished in: Journal of clinical laboratory analysis (2021)
TRF-Pro-CGG is under-expressed in PDAC and is associated with short clinical survival and poor prognosis. tRF-Pro-CGG is an independent prognostic factor, which highlights its role as a potential biomarker for PDAC progression and therapy.